Yes the outcome from Janssen study will be positive, if ProMarkerD can assess the effectiveness of Janssen's drug it means that it can also assess the effectiveness of competitor's drugs. This isn't exclusive. And then there's also the trial drugs. Huge opportunity.
PIQ may not be too far off from announcing the study results. This should be a big catalyst.
Ann: Proteomics International seeks FDA approval for PromarkerD, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.65M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 38.0¢ | $98.01K | 252.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9722 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 44999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |